Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously
Clinical trial NCT00788294 · COMPLETED
Trial details
- NCT number
- NCT00788294
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-06-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.